Year: 2025
Type: conference-paper
Abstract: Immunotherapy is a booming field in cancer care. To answer pan-cancer overarching questions related to this treatment, we are building IMODAR, collecting data from clinical and translational studies at KU Leuven and UZ Leuven. Progress has been made, but we also face challenges.
Authors: Kainat Jamil, Johan Van Lint, An Coosemans
Institution: KU Leuven
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4410356374